Gait Profile and Variables in Pediatric Rheumatic Disease Using a Smart Insole System

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-18
SponsorIstanbul University - Cerrahpasa

About this trial

In pediatric rheumatic diseases, joint swelling, effusion, tenderness, and painful restriction of joint movement, particularly in weight-bearing joints, frequently alter walking function. These changes affect temporal and spatial parameters of gait, as well as kinematic and kinetic characteristics, leading to functional limitations. Comprehensive physical assessments in patients may not always predict changes in gait parameters. Therefore, incorporating objective methods related to gait and balance into physical evaluations is essential for functional insights and clinical decision-making, aiming to prevent adaptive mechanisms that could negatively affect gait function in the long term. In this context, smart insoles have emerged as a new tool for gait analysis, offering an alternative to high-cost, lab-based equipment. The Digitsole Pro® system can measure gait profile and variables in real-life conditions. A review of the literature reveals no studies utilizing smart insole-based gait assessments in pediatric rheumatic patients. The aim of our study is to investigate the gait profile and variables of children and adolescents with pediatric rheumatic disease using the next-generation Digitsole Pro® smart insole system, and to compare the results with those of healthy peers.

Eligibility criteria

Qualifiers

Aged 6-18 years

Diagnosed with JIA or FMF at least 6 months ago at the Istanbul Medical Faculty Pediatric Rheumatology Clinic

Aged 6-18 years

Willing to participate in the study

Disqualifiers

History of trauma or surgery affecting the musculoskeletal system in the last 6 months

Presence of a chronic disease other than JIA or FMF

Acute pain for any reason

Visual or hearing problems

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

60 Participants
are grouped into 3 trial groups

Locations

This trial has no locations

Sponsors and collaborators

Istanbul University - Cerrahpasa

Lead sponsor

Istanbul Kent University

Sponsor institution